As immunologists have long understood, effective responses to foreign antigens require adjuvants. It is now apparent that the initiation of autoimmune disease is comparably facilitated by adjuvant activity. In the case of antinuclear antibodies, it seems that DNA itself can serve as an endogenous adjuvant. Similar to many of the microbial adjuvants, mammalian DNA mediates its effect through a Toll-like receptor--in this case, TLR9.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.rdc.2004.04.005 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!